Document is current
Any future updates will be listed below
-
Authors
Saridaki, Maria
Metallidis, Simeon
Grigoropoulou, Sotiria
Vrentzos, Emmanouil
Lada, Malvina
Argyraki, Katerina
Tsachouridou, Olga
Georgiadou, Anna
Vasishta, Anil
Giamarellos-Bourboulis, Evangelos J. https://orcid.org/0000-0003-4713-3911
-
Funding
Funding for this research was provided by:
Hellenic Institute for the Study of Sepsis
JoinStar, Hangzhou, China
- License Information
-
More Information
Article History
Received: 25 July 2020
Accepted: 28 December 2020
First Online: 29 January 2021
Compliance with ethical standards
:
: Anil Vasishta is consultant to JoinStar.EJ Giamarellos-Bourboulis has received honoraria (paid to the University of Athens) from AbbVie USA, Abbott CH, Angelini Italy, Brahms GmbH, InflaRx GmbH, MSD Greece, Pfizer Greece, and XBiotech Inc. He has received independent educational grants from AbbVie, Abbott CH, Astellas Pharma Europe, AxisShield, bioMérieux Inc., InflaRx GmbH, Novartis Inc., and XBiotech Inc. He has received funding from the FrameWork 7 program HemoSpec, from the Horizon2020 Marie-Curie project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and from the Horizon2020 HemoSpec (granted to the Hellenic Institute for the Study of Sepsis).All other authors have disclosed that they do not have any conflicts of interest relevant to this submission.
: Written informed consent was provided from all participants or their legal representatives. The study protocol was approved by the following Ethics Committee:• ATTIKON University General Hospital• AHEPA Thessaloniki University Hospital• Sismanogleion Athens General Hospital• Sotiria Athens General Hospital
: Not applicable.
Free to read: This content has been made available to all.
